Every parliamentary written question tabled by Esther McVey this session, with the full answer and department. See how every department answers, or back to the MP page.
Showing 101–115 of 115 · Department of Health and Social Care
Pursuant to the Answer of 18 November 2024 to Question 13773 on the Vaccine Damage Payment Scheme, how much his Department spent on legal fees defending against appeals.
Between 1 November 2021 and 1 December 2024, the total spent by the NHS Business Services Authority on behalf of the Department on legal fees to defend against appeals within the Vaccine Damage Payment Scheme was £50,608.
Pursuant to the Answer of 18 November 2024 to Question 13773 on the Vaccine Damage Payment Scheme, how many people were (a) assessed and (b) successful in each of those financial years; and what th
In the financial year (FY) 2022/23, 1,298 applications were assessed, and 72 applications were successful. In the FY 2023/24, 3,806 applications were assessed, and 99 applications were successful. In the FY 2024/25, 4,664 applications have been assessed, ...
How much has been spent on (a) reviewing applications to the Vaccine Damage Payment Scheme and (b) reviewing cases where a patient has challenged a decision in each of the last 5 years.
The Vaccine Damage Payment Scheme transferred from the Department for Work and Pensions to the NHS Business Services Authority (NHSBSA) in November 2021. We cannot provide any costings for the scheme during the period in which it was operated by the Depar...
With reference to section 4.2 of NHS key statistics: England, HC 07281, published on 25 October 2024, (a) what assessment he has made of the causes of the increase in life threatening ambulance cal
The rise in category 1 incidents reflects an increase in the proportion of patients’ ambulance services that have been determined to require an immediate face-to-face response. This may reflect a long-term trend of rising pressures on the health services ...
Pursuant to the Answer of 1 November 2024 to Question 9445 on Department of Health and Social Care: Public Appointments, what interests Alan Milburn has declared since being appointed as a Lead Non
The usual process of declarations of interest and agreement of appropriate mitigations for non-executive board member (NEBM) appointments was carried out, overseen by the Permanent Secretary. He is content that the process has been carried out, that appro...
Pursuant to the Answer of 31 October 2024 to Question 11248 on Coronavirus: Vaccination, what discussions the MHRA has had with industry safety regulators on the potential implications of the Pfize
The study abstract has been reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA), as part of its continuous post approval safety monitoring procedures for the Pfizer-BioNTech COVID-19 Vaccine (Comirnaty). The abstract is available at...
Pursuant to the Answer of 13 September 2024 to Question 4203 on Primodos: Research, when he expects the Medicines and Healthcare products Regulatory Agency to complete that review; and what steps h
The Medicines and Healthcare products Regulatory Agency (MHRA), together with the wider Government, are committed to reviewing any new scientific evidence since the conclusions of the 2017 independent Expert Working Group, convened by the Commission on Hu...
Pursuant to the Answer of 14 October 2024 to Question 6194 on Coronavirus: Vaccination, whether the Medicines and Healthcare products Regulatory Agency has made an assessment of the potential impli
The study abstract has been reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA), as part of its continuous post approval safety monitoring procedures for the Pfizer-BioNTech COVID-19 Vaccine (Comirnaty). The abstract is available at...
What his policy is on allowing people with financial interests in the private healthcare sector to be (a) employed in and (b) non executive directors at his Department.
All Department employees are subject to the Department’s policy on the Declaration and Management of Outside Interests. The policy is in alignment with the model Cabinet Office guidance in this area for Civil Servants, published on the GOV.UK website, whi...
On what dates Alan Milburn has attended Departmental meetings.
Central Government Corporate Transparency Commitments require Government Departments to publish details of Ministers and Senior Officials meetings with external individuals or organisations on a quarterly basis. We will be publishing the meetings that Ala...
Whether he has made an assessment of the potential implications for his policies of the study entitled Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-ana
All vaccines used in the United Kingdom are only authorised once they have met the robust standards of effectiveness, safety, and quality set by the UK’s independent regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).The monitoring ...
What information his Department holds on the cost to the public purse for hospital food in each of the last five years.
The following table shows the cost of inpatient food services, as well as other patient food services, in England over the last five years:YearInpatient food service costsOther patient food service costs2022/23£750,600,000£126,000,0002021/22£660,200,000£8...
Pursuant to the Answer of 5 September 2024 to Question 2887 on Food and Cosmetics: Pollutants, what assessment he has made of the implications for his policies of the International Agency for Resea
The International Agency for Research on Cancer conducts hazard assessments on substances in all applications. The Joint WHO/FAO Expert Committee on Food Additives as risk assessors looked at the safety of substances when used as a food additive, and foun...
With reference to the oral contribution of the Prime Minister in response to the question from the hon. Member Bolton South and Walkden of 4 September 2024, Official Report, which new Primodos scie
We remain hugely sympathetic to the families who believe that they have suffered due to the use of hormone pregnancy tests (HPTs). The Medicines and Healthcare products Regulatory Agency (MHRA), together with the wider Government, have committed to review...
Whether he has made an assessment of the potential risk of titanium dioxide in (a) food and (b) cosmetics.
The Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT) and the Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment have assessed the safety of titanium dioxide. The COT has concluded that it is unlikely that there would be a risk to health from current United Kingdom dietary exposures of E 171 titanium dioxide.